Back to Search
SHARON CHADA, PH.D.
PH.D.
Psychologist
NPI: 1396891032Individual
Specialties, Licenses & Credentials
PsychologistPrimary
Psychologist
Code: 103T00000X
32600(TX)
Research & Publications (20)
Apoptin studies illuminate intersection between lipidomics and tumor suppressors.
PMID 17164768·Mol Ther·2007
7-preclinical
mda-7 gene transfer sensitizes breast carcinoma cells to chemotherapy, biologic therapies and radiotherapy: correlation with expression of bcl-2 family members.
PMID 16282987·Cancer Gene Ther·2006
7-preclinical
mda-7/IL24 kills pancreatic cancer cells by inhibition of the Wnt/PI3K signaling pathways: identification of IL-20 receptor-mediated bystander activity against pancreatic cancer.
PMID 15851011·Mol Ther·2005
8-other
MDA-7/IL-24 is a unique cytokine--tumor suppressor in the IL-10 family.
PMID 15120650·Int Immunopharmacol·2004
6-review
Bystander activity of Ad-mda7: human MDA-7 protein kills melanoma cells via an IL-20 receptor-dependent but STAT3-independent mechanism.
PMID 15564140·Mol Ther·2004
8-other
Development of vaccines against self-antigens: the p53 paradigm.
PMID 12669451·Curr Opin Drug Discov Devel·2003
6-review
Killing of human melanoma cells induced by activation of class I interferon-regulated signaling pathways via MDA-7/IL-24.
PMID 18511292·Cytokine·2008
8-other
Development of Ad-mda7/IL-24-resistant lung cancer cell lines.
PMID 18059175·Cancer Biol Ther·2008
8-other
Interleukin-24 overcomes temozolomide resistance and enhances cell death by down-regulation of O6-methylguanine-DNA methyltransferase in human melanoma cells.
PMID 19056673·Mol Cancer Ther·2008
8-other
Adenoviral endoplasmic reticulum-targeted mda-7/interleukin-24 vector enhances human cancer cell killing.
PMID 18723497·Mol Cancer Ther·2008
7-preclinical
Phase I study of adenovirus p53 administered by bronchoalveolar lavage in patients with bronchioloalveolar cell lung carcinoma: ECOG 6597.
PMID 18757331·J Clin Oncol·2008
3-trial
MDA-7/IL-24, a novel tumor suppressor/cytokine is ubiquitinated and regulated by the ubiquitin-proteasome system, and inhibition of MDA-7/IL-24 degradation enhances the antitumor activity.
PMID 17828282·Cancer Gene Ther·2008
8-other
MDA-7/IL-24 suppresses human ovarian carcinoma growth in vitro and in vivo.
PMID 17274815·Mol Cancer·2007
7-preclinical
Inhibition of nuclear factor-kappaB augments antitumor activity of adenovirus-mediated melanoma differentiation-associated gene-7 against lung cancer cells via mitogen-activated protein kinase kinase kinase 1 activation.
PMID 17431123·Mol Cancer Ther·2007
7-preclinical
Vitamin E succinate in combination with mda-7 results in enhanced human ovarian tumor cell killing through modulation of extrinsic and intrinsic apoptotic pathways.
PMID 17449172·Cancer Lett·2007
8-other
mda-7/IL-24, novel anticancer cytokine: focus on bystander antitumor, radiosensitization and antiangiogenic properties and overview of the phase I clinical experience (Review).
PMID 17912425·Int J Oncol·2007
6-review
mda-7 In combination with bevacizumab treatment produces a synergistic and complete inhibitory effect on lung tumor xenograft.
PMID 17235306·Mol Ther·2007
7-preclinical
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 1331 GEMINI ST, SUITE 104
HOUSTON, TX 77058 - Phone
- (281) 956-1032
Quick Facts
- NPI
- 1396891032
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile